Yinghui Zhou

2.2k citations
38 papers · 1.4k indexed · 1 hit paper · h-index 16
Topics
Cancer-related molecular mechanisms research (5 papers)Immunotherapy and Immune Responses (4 papers)MicroRNA in disease regulation (3 papers)
Partner nations
ChinaUnited StatesUganda

In The Last Decade

Yinghui Zhou

35 papers receiving 1.4k citations

Hit Papers

Open-label Clinical Trial of Niraparib Combined With Pemb...20192026202120232019100200300

Peers

Yinghui Zhou
Comparison fields: 5 of 141
  • Molecular Biology 603
  • Oncology 532
  • Immunology 356
  • Cancer Research 282
  • Pulmonary and Respiratory Medicine 168
Replace Haidan Liu with:
Haidan Liu China
Xiaonan Hou United States
Jing Du China
Mingshan Niu China
Amelia D’Alessio Italy
Wanjin Li China
Samuel S. Freeman United States
Dandan Dong China
Neelu Puri United States
Hildur Helgadóttir Sweden
Yinghui Zhou relative to Haidan Liu China Haidan Liu's profile →
Citations per field
00.5×1.7×
Haidan Liu · 1×
Citations per year

Countries citing papers authored by Yinghui Zhou

Since Specialization
Citations

This map shows the geographic impact of Yinghui Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinghui Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinghui Zhou more than expected).

Fields of papers citing papers by Yinghui Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinghui Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinghui Zhou. The network helps show where Yinghui Zhou may publish in the future.

Co-authorship network of co-authors of Yinghui Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yinghui Zhou. A scholar is included among the top collaborators of Yinghui Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinghui Zhou. Yinghui Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 4
4 0
5 11
6 13
7 3
8 14
9 13
10 36
11 318
12 24
13 55
14 11
15 8
16 10
17 14
18 31
19 76
20 9

About Yinghui Zhou

Yinghui Zhou is a scholar working on Cancer Research, Immunology and Urology, having authored 38 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), Immunotherapy and Immune Responses (4 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Oncology (532 citations), Cancer Research (282 citations) and Immunology (356 citations). Yinghui Zhou has collaborated with scholars based in China, United States and Uganda. Frequent co-authors include Minghua Wang, Jiucun Wang, Shicheng Guo, Chenji Wang, Jin Li, Weilin Pu, Zhenglei He, Xueqing Zhang, Guangbo Zhang and Dong Jiang. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026